Atria Investments’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.53M Sell
76,970
-4,061
-5% -$313K 0.06% 343
2025
Q4
$6.43M Sell
81,031
-2,602
-3% -$205K 0.07% 299
2025
Q3
$6.31M Buy
83,633
+9,949
+14% +$682K 0.07% 309
2025
Q2
$5.08M Buy
73,684
+4,795
+7% +$314K 0.06% 378
2025
Q1
$4.67M Buy
68,889
+6,987
+11% +$418K 0.06% 393
2024
Q4
$2.78M Sell
61,902
-4,308
-7% -$242K 0.03% 554
2024
Q3
$4.16M Sell
66,210
-18,022
-21% -$1.05M 0.05% 414
2024
Q2
$4.97M Sell
84,232
-13,116
-13% -$820K 0.06% 334
2024
Q1
$7.76M Buy
97,348
+1,292
+1% +$98.7K 0.11% 225
2023
Q4
$7.58M Buy
96,056
+7,458
+8% +$531K 0.12% 209
2023
Q3
$6.19M Buy
88,598
+8,519
+11% +$604K 0.11% 227
2023
Q2
$5.54M Sell
80,079
-26,428
-25% -$1.88M 0.1% 237
2023
Q1
$7.91M Sell
106,507
-9,200
-8% -$771K 0.15% 163
2022
Q4
$10.8M Sell
115,707
-9,212
-7% -$889K 0.22% 101
2022
Q3
$11.9M Buy
124,919
+2,553
+2% +$253K 0.26% 80
2022
Q2
$11.3M Sell
122,366
-4,457
-4% -$435K 0.24% 89
2022
Q1
$12.8M Buy
126,823
+6,564
+5% +$690K 0.22% 101
2021
Q4
$12.4M Buy
120,259
+19,947
+20% +$1.84M 0.22% 106
2021
Q3
$8.51M Buy
100,312
+8,696
+9% +$728K 0.15% 149
2021
Q2
$7.64M Buy
91,616
+2,022
+2% +$166K 0.15% 157
2021
Q1
$6.74M Sell
89,594
-27
-0% -$1.97K 0.15% 160
2020
Q4
$6.12M Buy
89,621
+18,157
+25% +$1.18M 0.15% 162
2020
Q3
$4.17M Sell
71,464
-15,957
-18% -$993K 0.13% 185
2020
Q2
$5.68M Buy
+87,421
New +$5.51M 0.19% 129
2020
Q1
Sell
-52,002
Closed -$3.86M 677
2019
Q4
$3.86M Buy
52,002
+12,185
+31% +$856K 0.1% 183
2019
Q3
$2.51M Buy
39,817
+19,828
+99% +$1.17M 0.09% 184
2019
Q2
$1.18M Buy
19,989
+3,066
+18% +$165K 0.04% 366
2019
Q1
$913K Sell
16,923
-31,965
-65% -$1.97M 0.04% 383
2018
Q4
$3.2M Buy
48,888
+16,695
+52% +$1.25M 0.14% 114
2018
Q3
$2.53M Sell
32,193
-1,968
-6% -$141K 0.1% 182
2018
Q2
$2.2M Sell
34,161
-8,013
-19% -$528K 0.1% 219
2018
Q1
$2.62M Buy
42,174
+2,815
+7% +$202K 0.13% 168
2017
Q4
$2.85M Buy
39,359
+476
+1% +$34.6K 0.14% 161
2017
Q3
$3.16M Buy
38,883
+4,948
+15% +$391K 0.17% 118
2017
Q2
$2.73M Buy
33,935
+4,372
+15% +$345K 0.17% 128
2017
Q1
$2.32M Buy
29,563
+3,589
+14% +$287K 0.15% 150
2016
Q4
$2.05M Buy
25,974
+9,435
+57% +$763K 0.16% 123
2016
Q3
$1.47M Buy
16,539
+6,466
+64% +$610K 0.14% 143
2016
Q2
$962K Buy
10,073
+1,017
+11% +$101K 0.1% 171
2016
Q1
$939K Sell
9,056
-1,193
-12% -$116K 0.11% 155
2015
Q4
$959K Buy
10,249
+1,539
+18% +$151K 0.11% 149
2015
Q3
$840K Sell
8,710
-2,748
-24% -$289K 0.12% 130
2015
Q2
$1.2M Buy
11,458
+2,254
+24% +$230K 0.14% 107
2015
Q1
$950K Sell
9,204
-1,397
-13% -$141K 0.11% 157
2014
Q4
$1.02M Sell
10,601
-807
-7% -$71.1K 0.11% 156
2014
Q3
$908K Sell
11,408
-2,519
-18% -$199K 0.09% 187
2014
Q2
$1.05M Sell
13,927
-232
-2% -$17.5K 0.1% 161
2014
Q1
$1.06M Sell
14,159
-3,918
-22% -$277K 0.11% 163
2013
Q4
$1.29M Buy
18,077
+1,057
+6% +$67.9K 0.13% 134
2013
Q3
$966K Buy
17,020
+504
+3% +$30K 0.1% 160
2013
Q2
$944K Buy
+16,516
New +$957K 0.11% 109

Other funds holding CVS

Atria Investments's CVS Position: Q1 2026 in Review

Atria Investments reduced its CVS Health (CVS) stake by 5% in Q1 2026, selling an estimated $313K and leaving 76,970 shares worth $5.53M. The position accounts for 0.06% of the portfolio, ranked #343.

Atria Investments first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.8M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Atria Investments held 76,970 shares of CVS Health worth $5.53M as of Q1 2026.
  • Atria Investments sold 4,061 CVS Health shares in Q1 2026, an estimated $313K.
  • CVS Health made up 0.06% of Atria Investments's portfolio in Q1 2026, its #343 holding.
  • Atria Investments first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Atria Investments's CVS Health position peaked at $12.8M in Q1 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.